Fragile X syndrome

News and Video Search Results

News coverage

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

GlobeNewswire 09 May 2024

Company to host a webcast today at 8:30 a.m. Eastern TimeNEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp...

Fragile X Syndrome Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
GlobeNewswire 03 May 2024
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
GlobeNewswire 30 Apr 2024
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
ACN Newswire 19 Apr 2024
New technique sheds light on memory and learning
Science Daily 09 Apr 2024

0 shares 1 views

You might like

Fragile X syndrome media coverage

The BWB Awards at Biotech Week Boston Return for a Celebratory Gala September 23rd, 2024

Accesswire 02 Apr 2024

*BOSTON, MA / ACCESSWIRE / April 2, 2024 / *The BWB Awards at Biotech Week Boston returns for a night of dinner, drinks,..

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
GlobeNewswire 07 Feb 2024
Revolutionizing Care: NeuroQure's Groundbreaking Path to Treating Genetic Intellectual Disabilities
Upworthy 06 Nov 2023
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 03 Nov 2023
Discovery reveals fragile X syndrome begins developing even before birth
Science Daily 10 Oct 2023

Advertisement

More coverage

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

GlobeNewswire 29 Sep 2023

DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative..

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium
GlobeNewswire 14 Sep 2023
How Genetic Technologies Can Empower More People With Information
Accesswire 09 Aug 2023
Finalists Unveiled for 2023 BWB Awards: Biotech Week Boston's Dazzling Gala on September 18th, 2023
Accesswire 02 Aug 2023
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
Business Wire 01 Aug 2023